Use of physiologically based pharmacokinetic modeling to investigate individual versus population risk

This publication has 69 references indexed in Scilit:

• Investigation of the impact of pharmacokinetic variability and uncertainty on risks predicted with a pharmacokinetic model for chloroform
  Toxicology, 1996
• The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes
  Pharmacogenetics, 1994
• Coupling of computer modeling with in vitro methodologies to reduce animal usage in toxicity testing
  Toxicology Letters, 1993
• Improvements in Quantitative Noncancer Risk Assessment Sponsored by the Risk Assessment Specialty Section of the Society of Toxicology
  Fundamental and Applied Toxicology, 1993
• Demethylation Pathways in Caffeine Metabolism as Indicators of Variability in 1,1,1‐Trichloroethane Oxidation in Man
  Basic & Clinical Pharmacology & Toxicology, 1990
• Precision and sensitivity of pharmacokinetic models for cancer risk assessment: Tetrachloroethylene in mice, rats, and humans
  Toxicology and Applied Pharmacology, 1990
• Genetic heterogeneity of the human glutathione transfereses: A complex of gene families
  Pharmacology & Therapeutics, 1990
• Incorporation of biological information in cancer risk assessment: Example ? Vinyl chloride
  Cell Biology and Toxicology, 1989
• Physiologically based pharmacokinetics and the risk assessment process for methylene chloride
  Toxicology and Applied Pharmacology, 1987
• Age‐Related Changes in Carcinogen Metabolism
  Journal of the American Geriatrics Society, 1987